Search research articles
Contact Us
Filters
Showing results (1-10 of 85) with videos related to
Page
of 9
Sort By:
Arquivos Brasileiros De Endocrinologia E Metabologia
|
September 25, 2007
Clinical prognosis in BRAF-mutated PTC
Efisio Puxeddu, Sonia Moretti
Cancers
|
October 22, 2020
What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers
Efisio Puxeddu, Giovanni Tallini, Roberta Vanni
Current Opinion in Oncology
|
November 4, 2010
Targeted therapies for advanced thyroid cancer
Efisio Puxeddu, Serena Romagnoli, Massimo Eugenio Dottorini
Arquivos Brasileiros De Endocrinologia E Metabologia
|
February 4, 2010
Targeted molecular therapies in thyroid carcinoma
Serena Romagnoli, Sonia Moretti, Pasquale Voce, et al.
Journal of Molecular Endocrinology
|
February 18, 2011
Epigenetics of thyroid cancer and novel therapeutic targets
Diego Russo, Giuseppe Damante, Efisio Puxeddu, et al.
Frontiers in Endocrinology
|
May 14, 2021
Immune Landscape of Thyroid Cancers: New Insights
Elisa Menicali, Martina Guzzetti, Silvia Morelli, et al.
Trends in Endocrinology and Metabolism: TEM
|
March 14, 2008
Clinical implications of BRAF mutation in thyroid carcinoma
Efisio Puxeddu, Cosimo Durante, Nicola Avenia, et al.
Endocrine
|
November 6, 2015
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation
Silvia Morelli, Gianpaolo Reboldi, Sonia Moretti, et al.
European Journal of Endocrinology
|
May 26, 2020
THERAPY OF ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: from bench to bedside
Sonia Moretti, Elisa Menicali, Nicole Nucci, et al.
Expert Opinion on Therapeutic Patents
|
February 24, 2011
Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon?
Antonio Macchiarulo, Nicola Giacchè, Francesca Mancini, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 85) with videos related to
Sort By:
Page
of 9
Arquivos Brasileiros De Endocrinologia E Metabologia
|
September 25, 2007
Clinical prognosis in BRAF-mutated PTC
Efisio Puxeddu, Sonia Moretti
Cancers
|
October 22, 2020
What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers
Efisio Puxeddu, Giovanni Tallini, Roberta Vanni
Current Opinion in Oncology
|
November 4, 2010
Targeted therapies for advanced thyroid cancer
Efisio Puxeddu, Serena Romagnoli, Massimo Eugenio Dottorini
Arquivos Brasileiros De Endocrinologia E Metabologia
|
February 4, 2010
Targeted molecular therapies in thyroid carcinoma
Serena Romagnoli, Sonia Moretti, Pasquale Voce, et al.
Journal of Molecular Endocrinology
|
February 18, 2011
Epigenetics of thyroid cancer and novel therapeutic targets
Diego Russo, Giuseppe Damante, Efisio Puxeddu, et al.
Frontiers in Endocrinology
|
May 14, 2021
Immune Landscape of Thyroid Cancers: New Insights
Elisa Menicali, Martina Guzzetti, Silvia Morelli, et al.
Trends in Endocrinology and Metabolism: TEM
|
March 14, 2008
Clinical implications of BRAF mutation in thyroid carcinoma
Efisio Puxeddu, Cosimo Durante, Nicola Avenia, et al.
Endocrine
|
November 6, 2015
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation
Silvia Morelli, Gianpaolo Reboldi, Sonia Moretti, et al.
European Journal of Endocrinology
|
May 26, 2020
THERAPY OF ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: from bench to bedside
Sonia Moretti, Elisa Menicali, Nicole Nucci, et al.
Expert Opinion on Therapeutic Patents
|
February 24, 2011
Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon?
Antonio Macchiarulo, Nicola Giacchè, Francesca Mancini, et al.
Page
of 9